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ABSTRACT 
Objective: The present study was aimed to investigate the effects of alcoholic root extract of Ocimum sanctum, in human non-small cell lung 
carcinoma cell (NCI-H460).  
Methods: The effect of ethanolic extract of O. sanctum in NCI-H460 cell was investigated by the cell viability assay, generation of ROS in a cancer 
cell, apoptotic morphological changes and by mitochondrial membrane potential. 
Results: The cytotoxicity was observed by MMT assay. NCI-H460 cell was treated with various concentrations (10-150 µg/ml) of extract for 24 hr 
and 150 µg/ml showed a maximum decrease in cell viability. The extract (25-100µg/ml) showed significant increase ROS production in NCI-H460 
cell. It greatly inhibits cell viability and colony forming capacity of NCI-H460 cell, possibly because of increased oxidative stress. An increased 
apoptotic cell in Ocimum sanctum further shows its anticancer nature. Loss of mitochondrial membrane potential is an early stage of apoptosis. Our 
results showed that extract treatment caused serve loss of in NCI-H460 cell.  
Conclusion: The present study suggests that O. sanctum extract act by increasing oxidative damage in NCI-H460 cells.  
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INTRODUCTION 
Cancer, the second major cause of human death, spares neither men 
nor women. The American Cancer Society statistics estimated that 
about 1,665,540 new cases of cancer were expected to be diagnosed in 
2014. Though, different groups of drugs work in different ways to fight 
cancer cells and shrink tumors, nowadays, herbs are used for cancer 
remedy [1, 2]. Chemotherapy may be used alone for some types of 
cancer or in conjunction with other therapy such as radiation or 
surgery [3]. Recent researches revolve round the urgency to evolve 
suitable chemotherapy consistent with new discoveries in cell biology 
for the treatment of cancer with less or no toxic effect [4, 5]. 
Ocimum sanctum (O. sanctum) is a tropical annual herb and is a 
member of the family Lamiaceae (Labiatae). It shows various 
biological activities such as immunomodulation, anti-ulcer, anti-
inflammation, antimicrobial, antihypertensive, cardioprotective, 
hepatoprotective, antidiabetic, antifertility, radio protective and 
anti-carcinogenesis, etc [6-9]. The findings of Kim et al., (2010) 
supports that ethanolic extract of O. sanctum (EEOS)can be a potent 
anti-metastatic candidate which inactivate matrix metallo-
proteinase-9 (MMP-9) and enhance antioxidant enzymes [10]. 
Magesh et al., (2009) demonstrated that EEOS induces apoptosis in 
A549 cells via a mitochondrial caspase-dependent pathway and 
inhibits the in vivo growth of Lewis lung carcinoma animal model, 
suggesting that EEOS can be applied to lung carcinoma as a chemo 
preventive candidate [8]. Tae-kyung Kwak et al., 2014 suggested 
that anti-metastatic mechanism of EEOS is mediated by inhibition of 
PI3K/Akt in Osteopontin (OPN) treated NCI-H460 non-small cell 
lung cancer cells [11]. Extracts from Ocimum Sp. and 
Phytochemicals from O. sanctum like eugenol, rosmarinic acid, 
apigenin, my retinal, luteolin, β–sitosterol, and carnosic acid are 
reported to prevent chemical-induced skin, liver, oral, and lung 
cancers and to mediate these effects by increasing the antioxidant 
activity, altering the gene expressions, inducing apoptosis, and 
inhibiting angiogenesis and metastasis [12-15].  
The anticancer activity of O. sanctum extract has been proved 
against various cancer cells (both in vitro and in vivo) like human 
fibrosarcoma cells culture, Swiss albino mice bearing Ehrlich 
ascites carcinoma (EAC), hamster buccal pouch carcinogenesis, 
papillomas, etc. In the present study, we investigated the cytotoxic 
effect of Ocimum sanctum root extract in non-small cell lung 
carcinoma cell line. 
MATERIALS AND METHODS 
Plant material 
Fresh and healthy roots of O. sanctum were collected from 
Chidambaram. The plant was Identified (No-754) by Dr. N. 
Karmegan, Associate Professor, Department of Botany, Government 
Arts and Science College, Salem-636007, Tamil Nadu, India. 
Preparation of root extract 
The fresh roots of O. sanctum were finely minced and ground with 
ethanol  95% v/v with the help of homogenizer. The grounded 
material was filtered using white filter cloth. Then the solvent 
present in the filtrate was completely dried using boiling water bath 
at 50 °C under reduced pressure. The required material of O. 
sanctum was separated, and that crude ethanoic extract was 
investigated for anticancer studies.  
Drugs and chemicals 
3-(4, 5-dimethyl-2-thiaozolyl)-2, 5-diphenyl-tetrazolium bromide 
(MTT), 2-7-diacetyl dichloro fluorescein (DCFH-DH), Rhodamine 
123 (Rh 123), ethidium bromide, acridine orange, cell culture 
chemicals such as heat-inactivated fetal calf serum (FBS), RPMI-
1640, glutamine, penicillin-streptomycin, EDTA, trypsin, Ethyl 
alcohol and phosphate buffered saline (PBS) were purchased from 
Sigma chemical Co., St. Louis, USA.  
Preparation of drug 
O. sanctum extract was dissolved in 0.2% dimethyl sulfoxide 
(DMSO). The stock solution was diluted with sterile DMEM medium 
to arrive at 5, 10, 25, 50, 75, 100, 125 and 150 µg/ml of O. sanctum 
and was used for further studies. 
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Treatment procedure 
The NCI-H460 cells were treated with O. sanctum extract in different 
concentration and incubated at 37 °C in 5% CO2 incubator. After 24 h 
incubation, the cells were harvested by trypsinization for further 
experiments. 
Cell line 
The present work was carried out in human non-small cell lung 
cancer cell line (table 1). This cell line was obtained from National 
Centre for Cell Science (NCCS), Pune, India. 
 
Table 1: Characteristics of cell line used in this study 
Designation  NCI-H460 
Tissue Human nonsmall cell lung cancer 
Gene transfers vehicle T25-Flask 
Recommended media RPMI with 10%FBS 
Cell doubling time 12-hours 
Nature Radioresistant 
Other Recommended Cells are ready to expand next day 
 
Culturing cells 
The NCI-H460 cells were grown as a monolayer in RPMI medium 
supplemented with 10% FBS, 1% glutamine, and 100 U/ml 
penicillin-streptomycin at 37 °C in 5% CO2 atmosphere. Stocks were 
maintained in 25 cm2 tissue culture flasks. After cell numbers are 
counted, cells were seeded at 5 x 104cells per well in 24-well plates. 
Cells were harvested by trypsinization.  
Study groups 
Cells were divided into five groups (table 2).  
 
Table 2: Different groups of cells used in the study 
 Group I Control (Untreated cancer cells) 
 Group II O. sanctum with (25 µg/ml) 
 Group III O. sanctum (50 µg/ml) 
 Group IV O. sanctum (75 µg/ml) 
 Group IV O. sanctum (100 µg/ml) 
 
Measurement of cell proliferation (MTT assay) 
The proliferation activity of cell populations-untreated and treated with 
O. sanctum extract in a different concentration such as 10, 25, 50, 75, 
100, 125 and 150 µg/ml was determined by the MTT assay based on the 
detection of mitochondrial dehydrogenase activity in living cells [16]. 
Measurement of intracellular ROS in cells by spectrofluorimetric 
method 
ROS was measured by using a non-fluorescent probe, 2, 7,-diacetyl 
dichlorofluorescein diacetate (DCFH-DA) that can penetrate into the 
intracellular matrix of cells where it is oxidized by ROS to 
fluorescent dichlorofluorescein (DCF). The non-fluorescent DCFH-
DA is oxidized by intracellular ROS and forms the highly fluorescent 
DCF [17] which is measured spectrofluorimetrically at emission 
filters set at 485±10 nm and 530±12.5 nm respectively. 
Apoptotic morphological changes by acridine orange/ethidium 
bromide dual staining method 
Apoptotic nuclei exhibiting typical changes such as nuclear 
condensation and segmentation were stained by AO/EtBr [18]. O. 
sanctum extract treated and untreated cells (2 x 104/well) were 
seeded into the 6-well plate and incubated in CO2 incubator for 24 h 
and then the apoptotic morphological changes were observed using 
a fluorescence microscope with the blue filter. 
Changes in mitochondrial transmembrane potential  
Alteration in mitochondrial membrane potential (Depolarization) is 
an indication of early stages of apoptosis. Rhodamine 123 (Rh 123) 
is a lipophilic cationic dye, highly specific for mitochondria. 
Polarized mitochondria are marked by orange-red fluorescence and 
depolarized mitochondria are marked by green fluorescence. 
Statistical analysis 
All quantitative measurements were expressed as means±SD for 
untreated and O. sanctum extract-treated cells. The data were 
analyzed using one-way analysis of variance (ANOVA) on SPSS/PC 
(statistical package for social sciences, a personal computer) and the 
group means were compared by Duncan’s Multiple Range Test 
(DMRT). The results were considered statistically significant if the P 
value is less than 0.05  
RESULTS  
Effect of O. sanctum extract on cell proliferation in NCI-H460 cells 
(MTT Assay)  
The growth inhibitory effect of O. sanctum extract in NCI-H460 cells was 
measured by MTT assay. MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyl-tetrazolium bromide) assay, in which the yellow tetrazolium 
salt is metabolized by NAD-dependent dehydrogenase (inactive 
mitochondria) to form a dark blue formazan product and the absorbance 
is directly proportional to the number of viable cells. Effect of O. sanctum 
extract on cell proliferation was determined by MTT assay. NCI-H460 
cells proliferation was significantly inhibited by O. sanctum extract. The 
inhibitory effect was observed after 24 h incubation.   
Fig. 1 shows the changes in the levels % of cell viability in the 
untreated and O. sanctum extract-treated cells. 10 μg/ml of O. 
sanctum extract treatment has not showed significant (P<0.05) 
proliferation inhibition. 25, 50, 75 and 100 μg/ml of O. sanctum 
extract treatment significantly inhibits NCI-H460 cells. 100 μg/ml of 
O. sanctum extract treatment showed only 15% cell viability. Hence, 
for further experiment we have chosen 25, 50, 75 and 100 μg/ml of 
O. sanctum extract. 
 
 
Fig. 1: Effect of O. sanctum extract on cell proliferation in NCI-
H460 cells 
Values are given as mean ± SD of six experiments in each group. 
Values not sharing a common superscript differ significantly at 
P<0.05 (DMRT) 
 
Effect of O. sanctum extracts in generating ROS level in NCI-H460 
cells 
Cytotoxic drugs are known to induce oxidative stress through the 
generation of reactive oxygen species (ROS) resulting in the 
imbalance of prooxidants and antioxidants in the cells. Intracellular 
generation and accumulation of ROS such as superoxide anion, 
hydrogen peroxide, singlet oxygen, hydroxyl radical and peroxyl 
radical in the stressed cells overcome natural antioxidant defense 
causing damage to biological macromolecules including nucleic 
acids, proteins, and lipids. 
The levels of ROS was measured by using a non-fluorescent probe,  
2, 7,-diacetyl dichloro fluorescein (DCFH-DA) that can penetrate into 
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the intracellular matrix of cells where it is hydrolyzed by cellular 
esterases to form dichlorofluorescein (DCFH). The non-fluorescent 
DCFH is oxidized by intracellular ROS and forms the highly 
fluorescent DCF which is measured spectrofluorimetrically at 
emission filters set at 485±10 nm and 530±12.5 nm respectively. 
Levels of ROS in control and O. sanctum extract treated cells were 
depicted in fig. 2 and 3. O. sanctum extract treatment significantly 
increased ROS level in NCI-H460 cells. Among all the doses tested 
100 μg/ml of O. sanctum extract showed the maximum generation of 
ROS in NCI-H460 cells. 
 
 
Fig. 2: O. sanctum generates ROS level in NCI-H460 cells 
 
 
Fig. 3: Effect of O. sanctum on ROS levels in control and O. 
sanctum treated NCI-H460 cells 
Values are given as mean ± SD of six experiments in each group. 
Values not sharing a common superscript differ significantly at 
P<0.05 (DMRT) 
 
Effect of O. sanctum on apoptotic morphological changes in NCI-
H460 cells  
To confirm whether the cytotoxic effect induced by O. sanctum 
extract involves apoptosis, we observed morphological changes in 
the O. sanctum extract treated and untreated cells. The initial 
structural changes of apoptosis are condensation of the cytoplasm 
and nucleus, loss of microvilli and disruption of intracellular 
junctions. O. sanctum extract treated cancer cells were stained with 
acridine orange-ethidium bromide and incubated in CO2 incubator 
for 24 h at room temperature.  
Untreated control cells appeared green in color (acridine orange 
stained) whereas the O. sanctum treated cells appeared orange in 
color (ethidium bromide stained). Acridine orange is a cationic dye 
that enters only live cells and stain DNA and hence the live cells 
observed as green under blue emission. On the contrary, ethidium 
bromide stains DNA in the cells undergoing apoptosis and hence 
apoptotic cells appeared orange in color. 
Fig. 4 & 5 shows the effect of O. sanctum extract on apoptotic 
morphological changes. We observed 92% apoptotic cells in 100 
µg/ml of O. sanctum extract treated cells; 85% apoptotic cells in 75 
µg/ml of O. sanctum extract treated cells; 50 µg/ml of O. sanctum 
extract treatment showed 65% apoptotic cells and 25 µg/ml of O. 
sanctum extract treatment showed 45% apoptotic cells. 
 
 
Fig. 4: Effect of O. sanctum on apoptotic morphological changes 
in NCI-H460 cells 
 
 
Fig. 5: Effect of O. sanctum (24 h) on apoptotic morphological 
changes in control and O. sanctum extract treated NCI-H460 cells 
Values are given as mean ± SD of six experiments in each group. 
Values not sharing a common superscript differ significantly at 
P<0.05 (DMRT) 
 
O. sanctum extract modulates mitochondrial membrane 
potential in NCI-H460 cells 
The uptake of the cationic fluorescent dye, rhodamine 123, has been 
used for the estimation of mitochondrial membrane potential. Many 
of these probes can be classified as lipophilic cations or 
“redistribution dyes.” These compounds accumulate in the 
mitochondrial matrix because of their charge and solubility in both 
the inner mitochondrial membrane and matrix space. Alteration in 
mitochondrial membrane potential (ψm) is an indication of early 
stages of apoptosis. Rhodamine 123 (Rh 123) is a lipophilic cationic 
dye, highly specific for mitochondria. Polarized mitochondria are 
marked by orange-red fluorescence and depolarized mitochondria 
are marked by green fluorescence. Control cells appeared orange-
red in color whereas the O. sanctum extract treated cells appeared 
green in color. Rhodamine 123 is a lipophilic cationic dye that enters 
only live cells and stain mitochondrial DNA and hence the live cell 
mitochondria appeared orange-red in color under blue emission.  
Changes in mitochondrial membrane potential in control and O. 
sanctum extract treated cells were depicted in fig. 6 & 7. O. sanctum 
extract treatment significantly increased mitochondrial 
depolarization in NCI-H460 cells. Among all the doses tested 100 
μg/ml of O. sanctum extract showed high level of mitochondrial 
depolarization in NCI-H460 cells. 
Sridevi et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 4, 242-246 
245 
 
Fig. 6: O. sanctum modulates mitochondrial membrane 
potential in NCI-H460 cells 
 
 
Fig. 7: Effect of O. sanctum (24 h) on MMP alterations in control 
and O. sanctum treated NCI-H460 cells 
Values are given as mean ± SD of six experiments in each group. 




Plant-derived polyphenolic compounds include flavonoids, tannins, 
curcuminoids, gallocatechin, stilbenes such as resveratrol; 
anthocyanidins such as delphinidin possess a wide range of 
pharmacological properties and are considered to possess 
chemopreventive and therapeutic properties against cancer. 
Moreover, phenolic phytochemicals manage oxidation stress-related 
diseases due to its direct involvement in quenching the free radicals 
[19]. Anticancer mechanism of plant polyphenols involves 
mobilization of endogenous copper possibly chromatin-bound 
copper and the consequent prooxidant action [20]. It has also been 
suggested that the cell killing activity of plant phenolics exhibit 
prooxidant activity [21] and cytotoxic properties [22-24].  
In the present study, we evaluated the anticancer effect of O. 
sanctum extract in non-small cell lung cancer cell line (NCI-H460) in 
vitro. We have observed cytotoxicity of O. sanctum extract in NCI-
H460 cells. Hence, our result indicates that concentration of 
phytochemicals plays a role for cytotoxicity. Probably, at higher 
concentration O. sanctum extract exhibits prooxidant property. This 
prooxidant property might disrupt mitochondrial dehydrogenase 
activity. This might be the reason for increased cytotoxicity at higher 
doses. The previous study shows that the O. sanctum extract shows 
that more than70% of growth inhibition activity against colon (HT-
15 and HT-29), neuroblastoma (IMR-32) and lung cancer (A-159) 
cell lines and hence it has anticancer activity [25].  
Alcoholic root extract showed more degree of inhibition against the 
cell lines. Our results along with previous reports suggest that 
mitochondrial activity of cancer cells may be influenced by O. 
sanctum, and that might be the reason for increased cytotoxicity 
observed in O. sanctum extract-treated cells. 
Reactive oxygen species (ROS) are known to cause oxidative 
modification of DNA, proteins, lipids and cellular small molecules. 
Increased ROS levels are thought to constitute an essential step in 
cell death induction by many different cytotoxic drugs. ROS levels 
were assessed after 24 h of incubation with O. sanctum extract. DCF 
fluorescence was measured by spectrofluorometer/fluorescence 
microscope. Changes in the mean fluorescence intensity (MFI) 
relative to untreated control cultures were interpreted as increase 
or decrease of the amount of internal ROS.  
O. sanctum extract treatment caused a rapid increase of intracellular 
ROS in NCI-H460 cells (fig. 4). We further noticed that a significant 
increase in the ROS levels in 100 µg/ml O. sanctum treated cells. The 
increased ROS levels during O. sanctum extract treatment might be 
due to its prooxidant property. 
Previous studies suggest the protective effect of basil against 
oxidative DNA damage and mutagenesis [26]. In addition to 
scavenging of reactive oxygen species (ROS), chelation of metal ions 
(such as iron and cooper) which initiate radical reactions and 
inhibition of enzymes responsible for free radical generation [27], 
antioxidants can interfere with xenobiotic metabolizing enzymes, 
block activated mutagens/carcinogens, modulate DNA repair and 
even regulate gene expression [28, 29]. Based on these mechanisms 
may be important for their antimutagenic and anticarcinogenic 
properties [30]. 
The mitochondrion is one of the most important organelles in 
regulating cell death as well as a marker in apoptosis. Increased ROS 
formation followed by mitochondrial membrane depolarization in 
cell lines has been reported [31]. Mitochondrial dysfunction is also 
an early indicator of apoptosis in cell lines [32]. Rh was served to 
determine the alteration of mitochondrion membrane potential. We 
observed accumulation of Rh in the mitochondria of control cells 
(fig. 6) and the O. sanctum extract treated cells showed no uptake of 
Rh showing membrane potential change. Similar changes have been 
observed in aclarubicin treated human non-small lung cancer cell 
lines [33]. Also, cytotoxic chemotherapeutic drugs are targeted to 
produce ROS in cells or tissues [34].  
We have observed O. sanctum extract pretreatment significantly 
increased apoptotic morphological changes in NCI-H460 cells. The 
microscopical observation showed a typical morphology of 
apoptosis, i.e., cell pyknosis, chromosomal condensation and nuclear 
fragmentation in O. sanctum extract-treated cells. Apoptosis has 
been shown to play an important role in determining cellular 
cytotoxicity [35]. Apoptosis has been shown to be a significant mode 
of cell death after cytotoxic drug treatment [36]. The increased ROS 
levels and subsequent oxidative DNA damage might be the reason 
for increased apoptotic morphological changes in the O. sanctum 
extract-treated cells. Sun-Chae Kim et. al., 2010, has also reported 
the inhibitory effect of ethanol leaf extract of O. sanctum extract on 
lung metastasis using the mouse Lewis lung carcinoma (LLC) cells. It 
prevented cell adhesion and invasion of LLC cells to extracellular 
matrix (ECM) [10].  
Furthermore, there is evidence that O. sanctum extract has proven to 
be useful and effective in sensitizing conventional agents, prolonging 
survival time and preventing side effects of chemotherapy. It has 
also been used in polyherbal therapy with various important 
Ayurvedic herbs viz. Azadirachta indica, Curcuma longa, Embelica 
officinalis, Ocimum sanctum, Semecarpus anacardium, Tinospora 
cordifolia etc. Over the years, the herbal usage has been increased 
many folds and the conventional medical usage also shows the 
positive results. 
CONCLUSION 
Our results summarize that O. sanctum extract shows anticancer 
activity by decreasing cell proliferation, increasing intracellular ROS, 
alteration in mitochondrial membrane potential and apoptosis in 
NCI-H460 cell line. The results obtained from our investigation 
confirmed the therapeutic potency of the plants. Further research is 
warranted to isolate the phytochemicals (s) that is responsible for 
cancer cell apoptosis. 
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